Jonathan C. Yau

Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support.

Frank Dunphy, Gary Spitzer, Aman U. Buzdar et al. · Journal of Clinical Oncology · 1990 · 172 citations

Intensive Therapy, Breast Oncology, Medicine +14

Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support

Frank Dunphy, Gary Spitzer, Jane Fornoff et al. · Cancer · 1994 · 94 citations · Full text

Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.

Frances A. Shepherd, William K. Evans, R. MacCormick et al. · PubMed · 1987 · 81 citations

Peripheral Neuropathy, Tumor Microenvironment, Medicine +15

Chemotherapy following surgery for stages IE and IIE non-Hodgkin's lymphoma of the gastrointestinal tract.

Frances A. Shepherd, William K. Evans, G Kutas et al. · Journal of Clinical Oncology · 1988 · 73 citations

Large Bowel, Surgical Oncology, Gastroenterology +18

Antiandrogen withdrawal syndrome with nilutamide

S. Huan, Ronald G. Gerridzen, Jonathan C. Yau et al. · Urology · 1997 · 56 citations

Hormonal Contraceptive, Medicine, Pharmacotherapy +3